Invitation to Attend EuroMedLab 2019 in Barcelonaand Seoul 2020 WordLab Congresses
70th AACC Annual Scientific Meeting Press ProgramAnnouncement of next IFCC EuroMedLab and WorldLab Congresses
Announcement of next IFCC EuroMedLab and WorldLab Congresses
IMV, part of the Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2018 IMV ServiceTrak™ awards in clinical analyzers. Sysmex America, Inc. was recognized for: Hematology: •Best System Performance •Best Customer Satisfaction •Best Service
Novel findings unveiled at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo show that gender-affirming hormone therapy markedly impacts the results of common laboratory tests for transgender patients. This study underscores the need for transgender-specific reference intervals to ensure this underserved population receives accurate diagnoses and effective treatments.
AACC announced today the launch of a new credential for point-of-care testing professionals. This new certification – the first of its kind in the United States -- is designed for healthcare experts who perform diagnostic tests outside the central laboratory.
For decades, microbiologists have done their work by hand even as robotics and automation began to improve other laboratory processes. Until recently, the delicate techniques necessary to introduce mechanisms to microorganism study and analysis have been challenging for these divisions to automate. Now that's changing.
ARUP recently rolled out a next generation UM dashboard for clients—hospitals and healthcare organizations—that will allow them to further mine this data and make it actionable.
Ortho Clinical Diagnostics announced that, for the third year in a row, the Ortho Care™ service and support program was the highest-ranked original equipment manufacturer for overall service performance in the diagnostics industry.
Research announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo reveals that two out of three of the digital home ovulation tests sold by U.S. retailers do not accurately predict when a woman is ovulating. This information is critical for women trying to get pregnant and could improve their chances by helping them to better select at-home tests to guide intercourse timing.
Researchers have developed a novel test that rapidly distinguishes between type 1 and type 2 diabetes. This new method and a second study revealing gaps in care for women with gestational diabetes were presented today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, and could improve treatment for patients with all diabetes types across the board.
Scientists have discovered that in rheumatoid arthritis (RA) patients, lower levels of vitamin D are associated with increased disease severity. Their findings, announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, indicate that vitamin D supplementation could significantly improve quality of life for RA patients.
AACC is pleased to announce the recipients of the AACC 2018 Top Corporate Supporter Awards. This year, AACC recognizes 47 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
Performance Motion Devices today announced that its ATLAS® digital amplifiers, featuring the highest power density in the industry, can now be used with third party microprocessors or field programmable gate arrays (FPGAs) via Serial Peripheral Interface (SPI) communications.
Today biotech innovators will present portable tests that could help more patients get accurate diagnoses in a competition to win AACC’s Disruptive Technology Award.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it was selected for a gold-level Edison Award™ in the Best New Product Awards™ category for its VITROS® NEPHROCHECK® Test
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic System
Ortho Clinical Diagnostics received approval from the U.S. Food and Drug Administration for Ortho’s VITROS® Immunodiagnostic Products HBeAg Assay and the VITROS® Immunodiagnostic Products Anti-HBe Assay for use on the VITROS® 3600 Immunodiagnostic System and VITROS® 5600 Integrated System
Ortho Clinical Diagnostics announced that its VITROS® NEPHROCHECK® test received CE Mark. The VITROS® NEPHROCHECK® test is the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide
Ortho Clinical Diagnostics’ VITROS® XT 7600 Integrated System received CE Mark. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging and the potential to perform two separate lab tests simultaneously, Ortho introduces digital chemistry to clinical lab management
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will officially unveil the VITROS® XT 7600 Integrated System, now available in numerous countries that accept CE Mark, at the 2018 AACC Annual Scientific Meeting & Clinical Lab Expo
Sysmex, one of the fastest growing providers of diagnostic hardware and software in the U.S., celebrates its 50th anniversary in booth number 1231 at this year’s annual meeting of the American Association for Clinical Chemistry (AACC). The company is also sharing its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology.
Responding to customer requirements to handle increased volumes in decentralized clinical testing, MedTest Dx today announced the introduction of its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and the launch of its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform.
Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the Company”) announced today that it has entered into an agreement with US-based Janssen Pharmaceuticals, Inc. (hereinafter “Janssen”) to develop and commercialize an AMYLOID β 42/40 RATIO assay.
MedTest Holdings, the solution provider of choice offering integrated products and services for decentralized clinical diagnostic testing, today announced the debut of its new corporate name—MedTest Dx—at the upcoming 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Brandwidth Solutions, LLC, a full-service marketing agency addressing science-based businesses, has been recognized as Best Specialist Life Science Marketing Agency 2018-Pennsylvania by AI Global Media.
Debra Harrsch, founder and chief executive of Brandwidth Solutions, a full-service marketing agency addressing science-based businesses, received a Management Consulting Award from CEO Today magazine. The international publication “identifies the most hard-working and outstanding consultancy experts across the globe.”
SCIEX, a global leader in life science analytical technologies, advanced the accessibility of mass spectrometry in the clinical setting with new product introductions at AACC 2018. Today, SCIEX announced the launch of the new Topaz™ Prep Station, an automated sample preparation workstation that is ideal for labs managing high daily sample volumes, as well as the new automated Vitamin D 200A Assay Kit.
Hahn-Schickard enables complex clinical pictures to be diagnosed quickly and reliably directly at the point of care. The latest device generation allows the amplification of RNA and DNA by means of fast PCR in 20 - 25 minutes. This makes it possible, for example, to analyze a real patient sample fully automatically in 30 minutes. The device can also be used in the field of food analysis or environmental analysis.
At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—trailblazers in the field will share the pioneering research and technology paving the way for better clinical testing and patient care. From July 29–August 2 in Chicago, the meeting will feature more than 200 talks on a broad range of timely healthcare topics.
PixCell is a cell based diagnostics company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or calibrations. The HemoScreen is a portable and user-friendly test device that provides lab accurate results for the standard 20 Complete Blood Count (CBC) parameters, including a 5-part differential.
NAMSA®, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services, announced today the launch of its in vitro diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA’s “Uniquely IVD” regulatory, quality and clinical research services.
Equitech Enterprises Inc. is leading supplier of quality human blood, human blood components, and biological fluids to the research industry.
Neoteryx LLC today announced research recently published in the official peer-reviewed scientific journal of the European Federation of Clinical Chemistry and Laboratory Medicine, Clinical Chemistry and Laboratory Medicine. The research found that analysis of samples extracted from the company’s VAMS™ technology showed almost perfect agreement with results obtained from venous blood samples for HbA1c levels on a Tosoh G8 analyzer. The investigator-initiated clinical research study took place from June 2017 to January 2018 at Ghent University Hospital in Belgium. The study included 100 patients and was approved by the school’s Ethics Committee.
Neoteryx LLC, announced today the expansion of its patent-pending Mitra® Microsampling portfolio to now include a 30 µL tip size. The Mitra microsampling device which comes in a 10 µL, 20 µL and now 30 µL holds and transports a precise volume of blood typically collected from a finger prick.
Today, Neoteryx LLC, announced that it will supply its Volumetric Absorptive Microsampling (VAMS™) technology, in the form of the Mitra® microsampling device, to Alcala Labs of San Diego for a more efficacious, streamlined approach to monitor patients in recovery centers throughout the United States. By incorporating VAMS specimen collection and transportation technology into its CleanAssure™ clinical convenience kits and testing menu, Alcala Labs is the first to commercialize an offering to addiction recovery centers that analyzes a volumetrically accurate dried blood microsample collected from a simple finger prick to test for alcohol and opioids.
Techcyte Europe has been awarded the 2018 Healthcare Startup of the Year at the annual Healthcare Summit in Luxembourg.
Magnefy offer an additional performance-driven solid phase for magnetic particle-based assays and isolations, including SPRI-based* total DNA isolation. (*Solid phase reversible immobilization, which features the isolation of high-purity nucleic acid in the presence of NaCl and PEG.)
Festo AACC 2018 News — Festo introduces a compact rotary gripping module for handling vial and bottle caps. Booth #462
Festo AACC 2018 News -- Festo introduces its next generation liquid handling/modular dossing system. Booth #462
Equitech-Bio, Inc will attend and participate in AACC 2018 at Booth #3971.
Dynex Technologies announced today it has finalized a supply agreement with ZEUS Scientific (Branchburg, NJ) enabling ZEUS to sell Dynex instruments to the global clinical market.
Enzo is pleased to announce the launch of a new primary antibody validated for IHC, our p16INK4a monoclonal antibody. Our antibody is specific to the p16INK4A protein, a cyclin-dependent kinase inhibitor that plays an important regulatory role in the cell cycle.
IDEX Health & Science Announces Acquisition of Finger Lakes Instrumentation
GenPrime Inc., a leading provider of digital technology platforms and lateral flow readers, has announced the development of a new handheld version of its FDA-cleared diagnostic test reader...
GenPrime Inc., a leading provider of digital technology platforms and lateral flow readers, has announced the development of a new high-throughput version of its FDA-cleared diagnostic test reader...
Web Industries Inc., a leading medical contract manufacturing organization (CMO), will highlight its commitment to building lasting relationships with medical device makers as well as enhanced manufacturing capabilities for lateral flow immunoassay (LFI) devices.
Artel, is featuring a new demonstration at the 70th AACC Annual Scientific Meeting (Jul. 29 – Aug. 2). They will demonstrate how combining volume verification technology with a precise automated liquid handler can provide an optimized NGS workflow – speeding the process and eliminating doubt.
epMotion 5075 NGS solution comes with a new set of software features that was specifically developed for NGS customer needs, like intelligent selection of single and 8-channel dispensing tools, flexible number of samples, reduced dead-volume, more worktable capacity, email notification and more.
Two new centrifuges from Eppendorf: the smaller benchtop centrifuges with up to 24 spaces herald a new era, while Eppendorf is simultaneously expanding the product range of its large refrigerated benchtop centrifuges with a particularly versatile, high-capacity variant.